The in vitro experiments demonstrate that the PPAR coactivator-1α (PGC1α) binds to CCAAT/enhancer binding protein β (CEBPB) and increases FAO regulated by CPT1A in nasopharyngeal carcinoma (NPC) cells. The gene discussed is CEBPB; the disease is nasopharyngeal carcinoma.